Periodic Reporting for period 3 - ONCODESTROYER (Targeting cancer vulnerabilities in acute leukemia)

The overall objective of the ERC project (ONCODESTROYER) is to evaluate the therapeutic potential of a new class of anti-cancer drugs in acute myeloid leukemia (AML), using clinical study samples and mouse models. Acute myeloid leukemia accounts for 2 percent of all cancer...